These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3289990

  • 21. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S, Brange J, Burch A, Vølund A, Owens DR.
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [Abstract] [Full Text] [Related]

  • 22. Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections.
    Hanas SR, Carlsson S, Frid A, Ludvigsson J.
    Diabetes Care; 1997 Apr; 20(4):487-90. PubMed ID: 9096966
    [Abstract] [Full Text] [Related]

  • 23. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA, Sandoval D, Richardson MA, Tate D, Flakoll PJ, Davis SN.
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [Abstract] [Full Text] [Related]

  • 24. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP, Owens DR, Dolben J, Atiea JA, Dean JD, Kang S, Burch A, Brange J.
    BMJ; 1988 Nov 12; 297(6658):1236-9. PubMed ID: 3145064
    [Abstract] [Full Text] [Related]

  • 25. Intraregional differences in the absorption of unmodified insulin from the abdominal wall.
    Frid A, Linde B.
    Diabet Med; 1992 Apr 12; 9(3):236-9. PubMed ID: 1533580
    [Abstract] [Full Text] [Related]

  • 26. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE.
    J Clin Invest; 1985 Jun 12; 75(6):1842-51. PubMed ID: 3891786
    [Abstract] [Full Text] [Related]

  • 27. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S, Vaag A, Langkjaer L, Hougaard P, Markussen J.
    BMJ; 1989 Aug 12; 299(6696):415-9. PubMed ID: 2506998
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients.
    Hildebrandt P.
    Acta Physiol Scand Suppl; 1991 Aug 12; 603():41-5. PubMed ID: 1789128
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP, Neal L, Frankamp LM.
    Diabetes Care; 1993 Dec 12; 16(12):1592-7. PubMed ID: 8299455
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The influence of aprotinin on regional absorption of soluble human insulin.
    Owens DR, Vora JP, Birtwell J, Luzio S, Hayes TM.
    Br J Clin Pharmacol; 1988 Apr 12; 25(4):453-6. PubMed ID: 2454647
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Variation in absorption of NPH insulin due to intramuscular injection.
    Vaag A, Handberg A, Lauritzen M, Henriksen JE, Pedersen KD, Beck-Nielsen H.
    Diabetes Care; 1990 Jan 12; 13(1):74-6. PubMed ID: 2404719
    [Abstract] [Full Text] [Related]

  • 39. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S, Sotsky M, Shamoon H.
    J Clin Endocrinol Metab; 1990 Jan 12; 70(1):162-72. PubMed ID: 1967178
    [Abstract] [Full Text] [Related]

  • 40. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S, Brange J, Burch A, Vølund A, Owens DR.
    Diabetes Care; 1991 Nov 12; 14(11):942-8. PubMed ID: 1797506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.